# Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry

> **NCT03368820** · — · UNKNOWN · sponsor: **European Lung Cancer Working Party** · enrollment: 200 (estimated)

## Conditions studied

- Lung Neoplasm

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT03368820
- **Lead sponsor:** European Lung Cancer Working Party
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-04
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03368820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03368820, "Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03368820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*